等待开盘 04-02 09:30:00 美东时间
-0.140
-1.00%
今日重点评级关注:Guggenheim:维持Cabaletta Bio"买入"评级,目标价从15美元升至16美元;HC Wainwright & Co.:维持Palvella Therapeutics"买入"评级,目标价从255美元升至270美元
03-25 10:31
Mach Natural Resources LP (($MNR)) has held its Q4 earnings call. Read on for t...
03-18 08:19
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Mach Natural Resources业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - Q4总营收3.88亿美元,其中油气营收3.31亿美元,套期保值和中游业务贡献4200万美元 - 油气营收构成:石油占42%、天然气占44%、天然气液体占14% - Q4日产量15.4万桶油当量,其中石油17%、天然气68%、天然气液体15% **盈利能力:** - Q4调整后EBITDA为1.87亿美元 - Q4经营现金流为1.69亿美元 - 2025年全年现金资本回报率达23%(过去五年平均超过30%) **成本控制:
03-16 14:19
Mach Natural Resources (NYSE:MNR) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.26 by 89.39 percent. This is a 42.86 percent increase over earnings of $0.35 per share from
03-13 04:20
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
Mach Natural Resources LP (MNR) declares $0.53/share quarterly dividend. Forward yield 16.91% Payable March 12; for shareholders of record Feb. 26; ex-div Feb. 26. See MNR Dividend Scorecard, Yield Ch...
02-13 17:08
Keybanc analyst Tim Rezvan downgrades Mach Natural Resources (NYSE:MNR) from Overweight to Sector Weight.
01-16 19:25
今日重点评级关注:HC Wainwright & Co.:维持MetaVia Inc."买入"评级,目标价从12美元升至40美元;Canaccord Genuity:维持GH Research"买入"评级,目标价从35美元升至39美元
01-07 17:25
Stifel analyst Selman Akyol maintains Mach Natural Resources (NYSE:MNR) with a Buy and lowers the price target from $22 to $18.
01-06 21:40
William W. McMullen, Director of Mach Natural Resources GP LLC, along with BCE-Mach Aggregator LLC and Bayou City Energy Management LLC, reported the acquisition of common shares of Mach Natural Resou...
2025-12-11 05:06